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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
Carbon monoxide-
releasing agents in 
transplantation
Carbon monoxide (CO) joins other 
gases such as nitric oxide as a biological 
mediator of potent effects on a variety 
of cellular processes. As they report in 
this issue, Caumartin et al. found that 
when donor kidneys of rats were treated 
with a CO-releasing agent, they devel-
oped less ischemic damage, confirm-
ing previous findings in human kidney 
transplantation. The authors then stud-
ied the effect of CO on inflammation 
in endothelial cells in culture. They 
found that when oxidative damage was 
induced in these cells by application 
of cytokines such as tumor necrosis 
factor-a, pretreatment with CO could 
blunt many of the responses, such as the 
activation of nuclear factor-kB. These 
studies demonstrate the utility of this 
simple molecule in situations of inflam-
matory damage during transplantation. 
See page 1080.
Biomarker 
performance in  
acute kidney injury
The field of biomarkers in predicting 
diagnosis and prognosis of acute kidney 
injury is an evolving area of research. 
Recently, Endre et al. examined 529 
patients admitted to two intensive 
care units. They evaluated most of the 
biomarkers that have attracted atten-
tion in recent publications. They also 
stratified the patients by estimated 
glomerular filtration rate at the time of 
admission as well as the probable time 
of onset of the renal insult. The addition 
of this latter criterion improved the pre-





Identification of transplant recipients at 
greater risk for development of chronic 
rejection is difficult at present. Kimball 
et al. measured alloantibody levels in 
patients before and after transplantation. 
Using flow cytometry, they found that 69 
of 308 transplant patients had preopera-
tive crossreacting antibodies. After one 
year, they measured the levels of these 
alloantibodies using FACS as well as a 
more sensitive method. They found that 
two-thirds of the patients eliminated 
their formerly positive crossreacting anti-
bodies, and these patients had excellent 
results: 95% had surviving grafts after 3 
years. On the other hand, only 67% of 
those with maintained crossreacting 
antibodies had surviving grafts. These 
results show that sensitized patients often 
had excellent kidney survival, probably, 
in large part, because of their ability to 
eliminate the crossreacting antibodies. In 
addition, it seems that follow-up meas-
urements of the crossreacting antibodies 
might be a useful strategy for predicting 
chronic rejection. See page 1131.
